Clinical Trials Logo

Clinical Trial Summary

Rational of the study: for macular holes larger than 400 µm the rate of failure is of more than 20%. It is for these eyes that it is necessary to show the benefit of internal limiting membrane (ILM) peeling in term of vision and success rate. In order to test the benefit of this gesture, it is necessary to make a randomized study.

Primary objective: To show that the percentage of success (anatomical closing, confirmed by OCT) at third postoperative month is higher in the ILM peeling group.

Design of the study: Randomized multicentric study, in parallel groups, with individual benefit for the patient.

Tested Hypothesis: The success rate of the surgery of idiopathic macular holes larger than 400 µm is increased by the peeling of the MLI.

Awaited results: To show that the success rate of the surgery of idiopathic macular holes larger than 400 µm is improved by ILM peeling. This category could then have a success rate similar to the small holes. If this difference is not proven, it will remain no justification to continue this procedure which represents little risk but which is not either without consequence.


Clinical Trial Description

Rational of the study: for macular holes larger than 400 µm the rate of failure is of more than 20%. It is for these eyes that it is necessary to show the benefit of internal limiting membrane (ILM) peeling in term of vision and success rate. In order to test the benefit of this gesture, it is necessary to make a randomized study.

Primary objective: To show that the percentage of success (anatomical closing, confirmed by OCT) at three postoperative months is higher in the ILM peeling group.

Design of the study: Randomized multicentric study, in parallel groups, with individual benefit for the patient.

Tested Hypothesis: The success rate of the surgery of idiopathic macular holes larger than 400 µm is increased by the peeling of the MLI.

Secondary objectives: - Percentage of success according to the effective success of peeling (failure, partial peeling, peeling 360°) in the peeling group of the MLI. - Gain of ETDRS visual acuity in the third postoperative month.- Progression of cataract - Frequency of the complications.

Number of subjects and duration of the study: 80 patients older than 18 yo , presenting a macular hole > 400 µm, divided into two parallel groups will be included and followed up 3 months. The estimated total duration of the study is 27 months.

Statistical analysis: The percentages of success in the 2 groups will be compared by a Chi ² or Fisher exact test. The test Q of COCHRAN will be used to take into account the ordered character of the categories.

Intermediate Analysis: An intermediate analysis is envisaged. The procedure of adjustment of the risk of Lan and DeMets will be used.

Awaited results: To show that the success rate of the surgery of idiopathic macular holes larger than 400 µm is improved by ILM peeling. This category could then have a success rate similar to the small holes. If this difference is not proven, it will remain no justification to continue this procedure which represents little risk but which is not either without consequence. ;


Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00190190
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase N/A
Start date January 2005
Completion date May 2008

See also
  Status Clinical Trial Phase
Completed NCT01680068 - Air Tamponade in Macular Hole Surgery N/A
Recruiting NCT03465865 - Visual Acuity and Optical Coherence Tomography One Year After ILM-flap Transposition
Active, not recruiting NCT01969929 - Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy N/A
Completed NCT02011165 - An Objective Evaluation of Postoperative Positioning in Macular Hole Surgery N/A
Completed NCT01627977 - Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy Phase 3
Completed NCT00408720 - Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies N/A
Completed NCT00555269 - Membrane Blue Versus Infracyanine Green N/A
Terminated NCT02295943 - Objective Evaluation of Postoperative Positioning in Macular Hole Surgery N/A
Terminated NCT00333060 - Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal Phase 2
Completed NCT01083056 - Observational Study - ILM Peeling N/A
Completed NCT02930369 - Effects of Different Area of Internal Limiting Membrane Peeling (ILM) Peeling on Anatomical Outcomes in Macular Hole Surgery Phase 4
Recruiting NCT02067013 - Analysis of Aqueous and Vitreous Humor Phase 2
Completed NCT01959776 - Asymmetrical Recovery of Cone Outer Segment Tips and Foveal Displacement After Macular Hole Surgery N/A
Completed NCT05710458 - Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter N/A
Recruiting NCT02423213 - DISCOVER Study: Microscope-integrated Intraoperative OCT Study
Recruiting NCT01820520 - Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery Phase 3
Completed NCT01509092 - Comparative Study Between Early Vitrectomy and Observation for Spontaneous Closure of Traumatic Macular Hole N/A
Recruiting NCT01083004 - Brilliant Blue Versus Indocyanine Green Phase 3
Completed NCT01069029 - Combined Versus Successive Macular Hole and Cataract Surgery N/A
Completed NCT00737074 - Macular Hole in Diabetic Retinopathy N/A